Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies: Next Generation Personal Hematology

NCT04470947 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT04470947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04470947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies: Next Generation Personal Hematology
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Unknown status
Start date
June 10, 2020
Completion date
March 31, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced lymphoma, refractory acute myeloid leukemia, refractory leukemia, refractory lymphoma, refractory t-cell lymphoma